Cabinet gives nod to MoU between India, Kyrgyzstan to strengthen Healthcare Systems

Published On 2019-06-13 03:45 GMT | Update On 2019-06-13 03:45 GMT

New Delhi: The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi, has approved the proposal of the Ministry of Health & Family Welfare for signing a Memorandum of Understanding (MoU) between the Ministry of Health & Family Welfare of the Republic of India and the Ministry of Health of the Kyrgyz Republic in the field of Health.

Read Also:NHA inks MoU with National Cancer Grid to develop uniform standards of cancer patient care

Advertisement

Scope of Cooperation:

The Memorandum of Cooperation covers the following areas of cooperation:-

Strengthening of healthcare systems;

Non-communicable diseases, communicable diseases and anti-microbial resistance;

Development of hospital management systems and health information systems Hospital Management;

Maternal and child health;

Medical Researches;

Exchange of experience in the transplantation of kidney and liver, cardiac surgery, oncology, orthopaedics, traumatology, etc.;

Improving the capacity of human resources in the field of health;

Exchange of information and experience in the field of regulation of pharmaceuticals & medical devices circulation;

Exchange of experience and information on good practice of clinical trials of medicines and medical products;

Integrated surveillance of diseases;

Arranging visits for the experience exchange among physicians, nurses and specialists;

Exchange of experience on e-health;

Providing opportunities for health specialists to receive training and professional development at the "India-Kyrgyz Center for Information Technologies" with further internships in the Republic of India;

Health Tourism; and

Any other area of cooperation as may be mutually decided upon.

Implementation:

A Working Group will be set up to further elaborate the details of cooperation and to oversee the implementation of this Memorandum of Understanding.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medical Dialogues Bureau

Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Cabinet gives nod to MoU between India, Kyrgyzstan to strengthen Healthcare Systems

Similar News

Odisha CM inugurates 73 Ama Hospitals and dialysis centres in 15 Odisha districts

Unfortunate: PG Orthopedic Student at SSKM Hospital succumbs to dengue

GMC Rajouri gets dermatology wing to treat skin related cancer, diseases

LLRM Medical College: Another doctor booked for beating up patient kin

NHA Posts Decentralized Health Protocol (DHP) on Github platform asks private players to commit

Pregabalin effective in relieving symptoms in Functional Dyspepsia, finds study

JnK starts District Residency Program for PG Medical Students

Arthritis Drug linked to Heart-Related Problems and Cancer by FDA